Head-to-head · WeighScore
Heva Health vs myRocky
The verdict
Heva Health takes it — 69.7/100 to 51.4/100.
Heva Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Heva Health (hevahealth.com) is a LegitScript-certified concierge telehealth platform offering compounded GLP-1s with a 91-biomarker comprehensive lab panel, hormone optimization (HRT/TRT), and concierge care.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Heva Health | myRocky |
|---|---|---|
| WeighScore | 69.7/100 | 51.4/100 |
| Grade | C | C |
| Scorecard rank | #114 | #487 |
| Semaglutide | $149/mo (compounded) | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #114 · C
Strengths
- $149/mo entry pricing for compounded GLP-1 is competitive
- LegitScript Certified
- Claims licensure in all 50 states
- Comprehensive 91-biomarker lab panel bundled — a differentiator vs compounded-GLP-1-only peers
- Concierge care plus HRT/TRT alongside GLP-1 for an integrated longevity stack
Where it loses points
- Tirzepatide pricing not shown — only the generic $149/mo weight-loss entry
- Legal entity name and state of incorporation not disclosed
- Partner pharmacy not named
- Per-state availability not listed despite the all-50-states claim
- Brand-name GLP-1 options (Wegovy/Zepbound/Mounjaro/Ozempic/Foundayo) not addressed
Graded #487 · C
Strengths
- Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
- LegitScript Approved
- 42-state coverage with an 8-state expansion roadmap published
- Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription
Where it loses points
- Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
- Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
- Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
- Brand-only — no compounded option for cost-sensitive patients
- $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.